Geranylgeranylated, but not farnesylated, RhoB suppresses Ras transformation of NIH-3T3 cells

被引:50
作者
Mazières, J
Tillement, V
Allal, C
Clanet, C
Bobin, L
Chen, Z
Sebti, SM
Favre, G
Pradines, A
机构
[1] INSERM, U563, Inst Claudius Regaud,Dept Innovat Therapeut & Onc, Ctr Physiopathol Toulouse Purpan, F-31052 Toulouse, France
[2] Univ S Florida, H Lee Moffit Canc Ctr & Res Inst, Drug Discovery Program, Tampa, FL 33620 USA
[3] Univ S Florida, Dept Oncol & Biochem, Tampa, FL 33620 USA
关键词
Ras; RhoB; oncogenesis; prenylation;
D O I
10.1016/j.yexcr.2004.10.019
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
RhoB is a low molecular weight GTPase that is both farnesylated (RhoB-F) and geranylgeranylated (RhoB-GG) in cells. Based on data from rodent cell models, it has been suggested that RhoB displays differential effects on cell transformation, according to the nature of its prenylation. To test directly this hypothesis, we generated GTPase-deficient RhoB mutants that are exclusively either farnesylated or geranylgeranylated. We show that in Ras-transformed murine NIH-3T3 cells, RhoB-F enhances, whereas RhoB-GG and RhoB (F/GG) suppresses anchorage-dependent and -independent cell growth as well as tumor growth in nude mice. We then demonstrate that Ras constitutive activation of the tumor survival pathways Akt and NF-kappa B are blocked by RhoB-GG, but not by RhoB-F, providing further support for the opposing role of RhoB-F and RhoB-GG in Ras malignant transformation in NIH-3T3 cells. In addition, both RhoB (F/GG) and RhoB-GG induce apoptosis in Ras-transformed NIH-3T3 cells whereas RhoB-F has no effect. Our data demonstrate that RhoB-F and RhoB-GG which differ only by a 5-carbon isoprene behave differently in rodent cells highlighting the important role of prenyl groups in protein function and emphasize the potency of RhoB to regulate negatively the oncogenic signal. (c) 2004 Elsevier Inc. All rights reserved.
引用
收藏
页码:354 / 364
页数:11
相关论文
共 64 条
[1]   INTRACELLULAR-LOCALIZATION OF THE P21(RHO) PROTEINS [J].
ADAMSON, P ;
PATERSON, HF ;
HALL, A .
JOURNAL OF CELL BIOLOGY, 1992, 119 (03) :617-627
[2]  
ADAMSON P, 1992, J BIOL CHEM, V267, P20033
[3]   RhoB controls Akt trafficking and stage-specific survival of endothelial cells during vascular development [J].
Adini, I ;
Rabinovitz, I ;
Sun, JF ;
Prendergast, GC ;
Benjamin, LE .
GENES & DEVELOPMENT, 2003, 17 (21) :2721-2732
[4]  
Adnane J, 2002, CLIN CANCER RES, V8, P2225
[5]   RhoA prenylation is required for promotion of cell growth and transformation and cytoskeleton organization but not for induction of serum response element transcription [J].
Allal, C ;
Favre, G ;
Couderc, B ;
Salicio, S ;
Sixou, S ;
Hamilton, AD ;
Sebti, SM ;
Lajoie-Mazenc, I ;
Pradines, A .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (40) :31001-31008
[6]   RhoB prenylation is driven by the three carboxyl-terminal amino acids of the protein:: Evidenced in vivo by an anti-farnesyl cysteine antibody [J].
Baron, R ;
Fourcade, E ;
Lajoie-Mazenc, I ;
Allal, C ;
Couderc, B ;
Barbaras, R ;
Favre, G ;
Faye, JC ;
Pradines, A .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (21) :11626-11631
[7]   RhoB and the cellular response to farnesyltransferase inhibitors - The search for clues to cell death mechanisms [J].
Bernhard, EJ .
CANCER BIOLOGY & THERAPY, 2003, 2 (03) :281-282
[8]   Improved oligonucleotide uptake and stability by a new drug carrier, the SupraMolecular BioVector (SMBV) [J].
Berton, M ;
Sixou, S ;
Kravtzoff, R ;
Dartigues, C ;
Imbertie, L ;
Allal, C ;
Favre, G .
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH, 1997, 1355 (01) :7-19
[9]   Increasing complexity of Ras signaling [J].
Campbell, SL ;
Khosravi-Far, R ;
Rossman, KL ;
Clark, GJ ;
Der, CJ .
ONCOGENE, 1998, 17 (11) :1395-1413
[10]   Both farnesylated and geranylgeranylated RhoB inhibit malignant transformation and suppress human tumor growth in nude mice [J].
Chen, Z ;
Sun, JZ ;
Pradines, A ;
Favre, G ;
Adnane, J ;
Sebti, SM .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (24) :17974-17978